(R)-1-(Pyrrolidin-3-yl)piperidine dihydrochloride

Catalog No.: 
ACZWHY614
CAS No.: 
913702-35-9
Molecular Formula: 
C9H20Cl2N2
Molecular Weight: 
227.18
(R)-1-(Pyrrolidin-3-yl)piperidine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$69.00In stockInquiry
5g95%$342.00InquiryInquiry
25g95%$1693.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-1-(Pyrrolidin-3-yl)piperidine dihydrochloride
IUPAC Name(R)-1-(pyrrolidin-3-yl)piperidine dihydrochloride
MDL No.MFCD11974890
Molecular FormulaC9H20Cl2N2
Molecular Weight227.18
SMILES[H]Cl.[H]Cl.N1([C@H]2CNCC2)CCCCC1
InChI KeyGDPYVOIPMPHKGB-KLQYNRQASA-N
SynonymSCHEMBL1094728 | 1-[(3R)-Pyrrolidin-3-yl]piperidine--hydrogen chloride (1/2) | 1-(3R)-3-pyrrolidinyl-piperidine dihydrochloride | 1-[(3R)-3-pyrrolidinyl]-Piperidine(Hydrochloride)(1:2) | F75022 | CS-0007558 | DTXSID90736003 | (R)-1-(Pyrrolidin-3-yl)piperi
CAS No.913702-35-9
PubChem CID66905717

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACZWHY614 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZWHY614 route product structure diagram
    ACZWHY614913702-35-9In Stock
Inquiry

2. ACZWHY614 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZWHY614 route product structure diagram
    ACZWHY614913702-35-9In Stock
Inquiry

3. ACZWHY614 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZWHY614 route product structure diagram
    ACZWHY614913702-35-9In Stock
Inquiry

Comments (0)